drugset / Trial / NCT00513864

Assessment of Opioid Analgesia in Sickle Cell

NCT00513864

RandomizedCrossoverOpen-labelBasic science

Summary

To develop and validate a non-invasive, in vivo, phenotyping method for CYP2D6 using the non-injurious neuroselective electrical stimulation technique: pain perception threshold/pain tolerance threshold (PPT/PTT) in children and adolescents with sickle cell disease.

Timeline

Start
2006-11
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Codeine Small molecule 2 mg/kg Oral
Comparator Dextromethorphan Unknown 0.3 mg/kg Oral
Comparator Morphine Other / unclassified 0.15 mg/kg Intravenous

Indications